Monoaminergic effects of the unilateral blockade of orexin receptors (OX1R) in the enlarged amygdala under psychostimulant action
Psychopharmacology & biological narcology · 2023
DOI: 10.17816/phbn321621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychopharmacology & biological narcology, 2023. Verfasst von Inessa V. Karpova und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The search for new drugs potentially effective in stopping the development of pathological addictions is an urgent task of experimental psychopharmacology. AIM: To examine the participation of brain monoaminergic systems in the mechanisms of the blocking effect of SB-408124 on the self-stimulation of the lateral hypothalamus activated with the psychostimulant -phenylisopropylamine (PIPA) treatment. MATERIALS AND METHODS: Male Wistar rats pre-administered with psychostimulant (PIPA, 1 mg/kg intraperitoneally) were unilaterally injected with an orexin antagonist SB-408124 (1 g in 1 L) into the central nucleus of the amygdala or the bed nucleus of the stria terminalis (BNST). High-performance liquid chromatography with electrochemical detection was used to determine the levels of monoamines and their metabolites: norepinephrine (NA), dopamine (DA), serotonin (5-HT), dioxyphenylacetic (DOPAC), homovaniline (HVA), and 5-hydroxyindolacetic (5-HIAA) acids on the left and right sides of the prefrontal cortex, hippocampus, striatum, and olfactory tubercle. RESULTS: Under the action of PIPA, microinjections of SB-408124 into the right central nucleus of the amygdala induced the following effects: prefrontal cortex, an increase in the levels of HVA and 5-HT on the right side and 5-HIAA on the left; hippocampus, bilateral increase in the levels of NA and HVA and 5-HT on the right; striatum, bilateral increase in the level of DA and the left-sided increase in HVA, 5-HT, and 5-HIAA. Microinjections into the left central nucleus of the amygdala caused a right-sided decrease in NA levels, an increase in 5-HT levels, and a left-sided decrease in DA and DOPAC levels in the striatum and a left-sided increase in HVA level in the olfactory tubercle. Microinjections into the right BNST caused a left-sided decrease in the levels of NA and DA in the prefrontal cortex, bilateral decrease in DOPAC levels, a right-sided increase in 5-HT levels, and a left-sided increase in 5-HIAA levels in the striatum; and a left-sided increase in HVA levels in the olfactory tubercle. Microinjections into the left BNST caused increased 5-HT levels in the left striatum and decreased DOPAC and 5-HIAA levels in the left olfactory tubercle. CONCLUSIONS: Right-sided microinjections cause a greater number of changes in monoamine metabolism than left-sided ones. The introduction of SB-408124 into the right structures of the enlarged amygdala increases 5-HIAA levels in the left striatum, whereas microinjections in BNST lead to increased 5-HT levels in the ipsilateral striatum and in the contralateral in the central nucleus of the amygdala
Zitieren
APA
Karpova, I. V., Bychkov, E. R., Lebedev, A. A., & Shabanov, P. D. (2023). Monoaminergic effects of the unilateral blockade of orexin receptors (OX1R) in the enlarged amygdala under psychostimulant action. Psychopharmacology & biological narcology. https://doi.org/10.17816/phbn321621
Vancouver
Karpova IV, Bychkov ER, Lebedev AA, Shabanov PD. Monoaminergic effects of the unilateral blockade of orexin receptors (OX1R) in the enlarged amygdala under psychostimulant action. Psychopharmacology & biological narcology. 2023. doi:10.17816/phbn321621
BibTeX
@article{Karpova2023,
author = {Karpova, Inessa V. and Bychkov, Eugeny R. and Lebedev, Andrei A. and Shabanov, Petr D.},
title = {Monoaminergic effects of the unilateral blockade of orexin receptors (OX1R) in the enlarged amygdala under psychostimulant action},
journal = {Psychopharmacology & biological narcology},
year = {2023},
doi = {10.17816/phbn321621}
}
EUVIMED